Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1259347.RAU18ekKKpsw0XZeE8Cf8Uak9uap4E3pZfxKUdvob5CEI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1259347.RAU18ekKKpsw0XZeE8Cf8Uak9uap4E3pZfxKUdvob5CEI130_assertion type Assertion NP1259347.RAU18ekKKpsw0XZeE8Cf8Uak9uap4E3pZfxKUdvob5CEI130_head.
- NP1259347.RAU18ekKKpsw0XZeE8Cf8Uak9uap4E3pZfxKUdvob5CEI130_assertion description "[Recently, two multicenter, double-blind, placebo-controlled clinical trials in Japan (Phase III) and the USA (Phase II) showed the benefits of hepatocyte growth factor (HGF) gene therapy for CLI patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259347.RAU18ekKKpsw0XZeE8Cf8Uak9uap4E3pZfxKUdvob5CEI130_provenance.
- NP1259347.RAU18ekKKpsw0XZeE8Cf8Uak9uap4E3pZfxKUdvob5CEI130_assertion evidence source_evidence_literature NP1259347.RAU18ekKKpsw0XZeE8Cf8Uak9uap4E3pZfxKUdvob5CEI130_provenance.
- NP1259347.RAU18ekKKpsw0XZeE8Cf8Uak9uap4E3pZfxKUdvob5CEI130_assertion SIO_000772 25633211 NP1259347.RAU18ekKKpsw0XZeE8Cf8Uak9uap4E3pZfxKUdvob5CEI130_provenance.
- NP1259347.RAU18ekKKpsw0XZeE8Cf8Uak9uap4E3pZfxKUdvob5CEI130_assertion wasDerivedFrom befree-2016 NP1259347.RAU18ekKKpsw0XZeE8Cf8Uak9uap4E3pZfxKUdvob5CEI130_provenance.
- NP1259347.RAU18ekKKpsw0XZeE8Cf8Uak9uap4E3pZfxKUdvob5CEI130_assertion wasGeneratedBy ECO_0000203 NP1259347.RAU18ekKKpsw0XZeE8Cf8Uak9uap4E3pZfxKUdvob5CEI130_provenance.